CD8A and COVID-19: We found that COVID-19 vaccination enhanced the mobilization of SARS-CoV-2-reactive TNFα-producing CD4+ and CD8+ T cells, and this enhancement was significant after the second dose of the vaccine was administered (Figures 2B, C, top panels).